Impact of a pharmacist-led telehealth oral chemotherapy clinic
- 5 February 2022
- journal article
- research article
- Published by Oxford University Press (OUP) in American Journal of Health-System Pharmacy
- Vol. 79 (11) , 896-903
Abstract
Purpose: Oral oncolytics come with significant concerns of noncompliance due to complex regimens, adverse effects, and high overall costs. The Geisinger Oral Chemotherapy Clinic is a fully telephone-based medication therapy disease management (MTDM) program designed to integrate pharmacists as advanced practitioners in hematology/oncology clinics for comanagement of oral chemotherapy. Summary: To date, Geisinger has 11 oncology clinics and 3 full-time pharmacists designated to the management of oral chemotherapy. Pharmacists receive referrals for comanagement of patients starting oral oncolytics. Under a collaborative practice agreement, they can order laboratory tests as well as supportive care medications and refills. Pharmacists review planned therapies, perform medication reconciliations, and provide medication counseling. Once treatment has been initiated, pharmacists contact patients for laboratory and toxicity assessments. The clinic incorporates the use of customized smart data elements within the electronic medical record to collect data regarding pharmacist interventions and time allocations in the clinic. As of March 31, 2021, the clinic was actively following approximately 1,100 patients, resulting in an average of 80 to 90 encounters per day for new referrals, chemotherapy education, and laboratory and toxicity assessments. Approximately 2,113 patients were followed from December 1, 2019, to March 31, 2021, with 46,929 interventions documented. Conclusion: By obtaining provider buy-in for pharmacy services, acquiring enough personnel resources to meet the needs of the growing patient population and respective therapies, and proper utilization of technology, the program has thrived, allowing for increased provider and patient satisfaction. Future goals include expanding collection of pharmacist intervention metrics and analysis of patient perceptions of services provided by the clinic.Keywords
This publication has 11 references indexed in Scilit:
- Pharmacist value-added to neuro-oncology subspecialty clinics: A pilot study uncovers opportunities for best practices and optimal time utilizationJournal of Oncology Pharmacy Practice, 2020
- Evaluation of a Pharmacist Led Oral Chemotherapy Clinic: A Pilot Program in the Gastrointestinal Oncology Clinic at an Academic Medical CenterPharmacy, 2020
- 2018 Hematology/Oncology Pharmacist Association Best Practices for the Management of Oral Oncolytic Therapy: Pharmacy Practice StandardJournal of Oncology Practice, 2019
- Telemedicine in Cancer CareAmerican Society of Clinical Oncology Educational Book, 2018
- Practice model: Establishing and running an oral chemotherapy management clinicAsia-Pacific Journal of Oncology Nursing, 2017
- Medication therapy disease management: Geisinger’s approach to population health managementAmerican Journal of Health-System Pharmacy, 2017
- ASHP Statement on TelepharmacyAmerican Journal of Health-System Pharmacy, 2017
- 2016 Updated American Society of Clinical Oncology/Oncology Nursing Society Chemotherapy Administration Safety Standards, Including Standards for Pediatric OncologyOncology Nursing Forum, 2017
- Roles for Pharmacy Technicians in Medication Reconciliation During Transitions of CareJournal of Pharmacy Technology, 2016
- Impact of a pharmacist-led oral chemotherapy-monitoring program in patients with metastatic castrate-resistant prostate cancerJournal of Oncology Pharmacy Practice, 2016